Editorial
Exploring complement activation to develop biomarkers for systemic lupus erythematosus†
George C. Tsokos,
Corresponding Author
George C. Tsokos
Walter Reed Army Institute of Research and Uniformed Services University of Health Sciences, Silver Spring, Maryland
Building 503, Room 1A32, Walter Reed Army Institute of Research, Silver Spring, MD 20910Search for more papers by this authorGeorge C. Tsokos,
Corresponding Author
George C. Tsokos
Walter Reed Army Institute of Research and Uniformed Services University of Health Sciences, Silver Spring, Maryland
Building 503, Room 1A32, Walter Reed Army Institute of Research, Silver Spring, MD 20910Search for more papers by this author†
The opinions expressed herein are those of the author and do not reflect those of the Department of Defense or the Army.
REFERENCES
- 1 Boackle SA, Morris MA, Holers VM, Karp DR. Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells. J Immunol 1998; 161: 6537–43.
- 2 Manderson AP, Botto M, Walport MJ. The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol 2004; 22: 431–56.
- 3 Bohana-Kashtan O, Ziporen L, Donin N, Kraus S, Fishelson Z. Cell signals transduced by complement. Mol Immunol 2004; 41: 583–97.
- 4 Tsokos CG, Fleming SD. Autoimmunity, complement activation, tissue injury, and back. Curr Dir Autoimmun 2004; 7: 149–64.
- 5 Hajela K, Kojima M, Ambrus G, Wong KH, Moffatt BE, Ferluga J, et al. The biological functions of MBL-associated serine proteases (MASPs). Immunobiology 2002; 205: 467–75.
- 6 Holers VM, Thurman JM. The alternative pathway of complement in disease: opportunities for therapeutic targeting. Mol Immunol 2004; 41: 147–52.
- 7 Yang Y, Chung EK, Zhou B, Lhotta K, Hebert LA, Birmingham DJ, et al. The intricate role of complement component C4 in human systemic lupus erythematosus. Curr Dir Autoimmun 2004; 7: 98–132.
- 8 Pillemer SR, Austin HA III, Tsokos GC, Balow JE. Lupus nephritis: association between serology and renal biopsy measures. J Rheumatol 1988; 15: 284–8.
- 9 Moulds JM, Warner NB, Arnett FC. Complement component C4A and C4B levels in systemic lupus erythematosus: quantitation in relation to C4 null status and disease activity. J Rheumatol 1993; 20: 443–7.
- 10 Finco O, Li S, Cuccia M, Rosen FS, Carroll MC. Structural differences between the two human complement C4 isotypes affect the humoral immune response. J Exp Med 1992; 175: 537–43.
- 11
Ho A,
Barr SG,
Magder LS,
Petri M.
A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus.
Arthritis Rheum
2001;
44:
2350–7.
10.1002/1529-0131(200110)44:10<2350::AID-ART398>3.0.CO;2-A CAS PubMed Web of Science® Google Scholar
- 12 Manzi S, Rairie JE, Carpenter AB, Kelly RH, Jagarlapudi SP, Sereika SM, et al. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity. Arthritis Rheum 1996; 39: 1178–88.
- 13 Buyon JP, Tamerius J, Belmont HM, Abramson SB. Assessment of disease activity and impending flare in patients with systemic lupus erythematosus: comparison of the use of complement split products and conventional measurements of complement. Arthritis Rheum 1992; 35: 1028–37.
- 14 Manzi S, Navratil JS, Ruffing MJ, Liu CC, Danchenko N, Nilson SE, et al. Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus. Arthritis Rheum 2004; 50: 3596–604.
- 15 Wilson JF, Wong WW, Schur PH, Fearon DT. Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus. N Engl J Med 1982; 307: 981–6.
- 16 Ross GD, Yount WJ, Walport MJ, Winfield JB, Parker CJ, Fuller CR, et al. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation. J Immunol 1985; 135: 2005–14.
- 17 Aguado MT, Lambris JD, Tsokos GC, Burger RZ, Bitter-Suermann D, Tamerius JD, et al. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation: relationship between immune complex levels, state of C3 and numbers of receptors for C3b. J Clin Invest 1985; 76: 1418–26.
- 18 Illei GG, Tackey E, Lapteva L, Lipsky PE. Biomarkers in systemic lupus erythematosus. I. General overview of biomarkers and their applicability. Arthritis Rheum 2004; 50: 1709–20.
